Arcoma Ab Stock Net Income
| ARCOMA Stock | SEK 10.50 0.20 1.87% |
Arcoma AB fundamentals help investors to digest information that contributes to Arcoma AB's financial success or failures. It also enables traders to predict the movement of Arcoma Stock. The fundamental analysis module provides a way to measure Arcoma AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Arcoma AB stock.
Arcoma |
Arcoma AB Company Net Income Analysis
Arcoma AB's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Arcoma AB Net Income | (7.47 M) |
Most of Arcoma AB's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arcoma AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Arcoma AB reported net income of (7.47 Million). This is 102.19% lower than that of the Healthcare sector and 103.14% lower than that of the Medical Devices industry. The net income for all Sweden stocks is 101.31% higher than that of the company.
Arcoma Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Arcoma AB's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Arcoma AB could also be used in its relative valuation, which is a method of valuing Arcoma AB by comparing valuation metrics of similar companies.Arcoma AB is currently under evaluation in net income category among its peers.
Arcoma Fundamentals
| Return On Equity | 0.0423 | |||
| Return On Asset | 0.0218 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 112.49 M | |||
| Shares Outstanding | 13.05 M | |||
| Shares Owned By Insiders | 46.73 % | |||
| Shares Owned By Institutions | 25.01 % | |||
| Price To Earning | 70.28 X | |||
| Price To Book | 2.26 X | |||
| Price To Sales | 0.97 X | |||
| Revenue | 117.13 M | |||
| Gross Profit | 55.29 M | |||
| EBITDA | (2.03 M) | |||
| Net Income | (7.47 M) | |||
| Cash And Equivalents | 811 K | |||
| Cash Per Share | 0.06 X | |||
| Total Debt | 1.81 M | |||
| Debt To Equity | 0.43 % | |||
| Current Ratio | 1.46 X | |||
| Book Value Per Share | 3.48 X | |||
| Cash Flow From Operations | (1.93 M) | |||
| Earnings Per Share | (0.81) X | |||
| Target Price | 12.0 | |||
| Number Of Employees | 24 | |||
| Beta | 1.08 | |||
| Market Capitalization | 146.18 M | |||
| Total Asset | 79.27 M | |||
| Retained Earnings | (6 M) | |||
| Working Capital | 15 M | |||
| Current Asset | 47 M | |||
| Current Liabilities | 32 M | |||
| Z Score | 49.0 | |||
| Net Asset | 79.27 M |
About Arcoma AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Arcoma AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arcoma AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arcoma AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Arcoma Stock
Arcoma AB financial ratios help investors to determine whether Arcoma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arcoma with respect to the benefits of owning Arcoma AB security.